Brief: TC Biopharm Announces Pricing Of $3.5 Million Public Offering
19/12/2023 13:14
Dec 19 (Reuters) - TC BioPharm Ltd T0Uy.F :
* TC BIOPHARM ANNOUNCES PRICING OF $3.5 MILLION PUBLIC
OFFERING
Source text for Eikon: ID:nPn1R9W55a
Further company coverage: T0Uy.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TC Biopharm (Holdings)
See all newsBrief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: TC BioPharm Announces Complete Response In Minimal Residual Disease Patient
Brief: TCBP Announces Non-Binding Letter Of Intent To Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Brief: TC Biopharm's Data Show A Favorable Response In Patients With Relapse Or Refractory AML
Brief: TCBP Trading Continues Unabated On Nasdaq Stock Exchange